BioCryst Pharmaceutical Inc. (BCRX)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

4505 EMPEROR BOULEVARD DURHAM, NC 27703

BioCryst Pharmaceutical Inc. operates as a biopharmaceutical company which uses structure-based drug design to discover and design novel, small-molecule pharmaceutical products for the treatment of cancer, cardiovascular and autoimmune diseases and viral infections.

Data based on most recent fiscal year report
Market Cap480.338 Million Shares Outstanding98.43 Million Avg Volume2.27 Million
1-Yr BETA vs S&P TR Current Ratio1.68 Quick Ratio1.68
View SEC Filings from BCRX instead.
Q2 2019 All Institutions Hedge Funds 1
To trade BCRX now:
Filers who had this stock in their top 10: 2 0 (0.0%)
13F Filers holding this stock: 115 23 (2.38%)
Aggregate 13F shares on 06/30/2019: 100.143 Million 40.426 Million
Aggregate 13F shares on 03/31/2019: 101.46 Million 45.071 Million
Percent change: -1.30% -10.31%
Funds creating new positions: 16 5
Funds Adding to an existing position: 44 9
Funds closing out their position: 32 11
Funds reducing their position: 29 9
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BCRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COHEN FRED E

  • Director
75,188 2019-10-01 0

ERCK STANLEY C PRESIDENT AND CEO

  • Officer
  • Director
0 2019-09-26 1

THACKRAY HELEN M.

  • Director
0 2019-09-20 2

HIGGINS JOHN L CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-09-19 0

PATEL SANJ K CHAIRMAN & CEO

  • Officer
  • Director
0 2019-09-17 0

HUTSON NANCY J

  • Director
43,046 2019-09-01 2

INGRAM ROBERT ALEXANDER

  • Director
28,088 2019-09-01 2

HEGGIE THERESA

  • Director
1,672 2019-09-01 4

ASELAGE STEVE

  • Director
6,672 2019-09-01 6

ABERCROMBIE GEORGE B

31,394 2019-08-31 1

BAKER BROS. ADVISORS LP

BAKER BROS. INVESTMENTS II, L.P.

BAKER BROS. INVESTMENTS, L.P.

BAKER/TISCH INVESTMENTS, LP

14159, L.P.

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
  • 10% Owner
9,471,630 2019-08-29 0

LEE KENNETH B JR

  • Director
12,071 2019-08-16 1

BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS (GP) LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
4,685,574 2019-07-01 0

SNIECINSKI MEGAN CHIEF BUSINESS OFFICER

  • Officer
0 2019-07-01 2

SEIDENBERG BETH C

  • Director
4,124,036 2019-06-30 0

JENSEN PEDER

  • Director
0 2019-06-19 0

STONEHOUSE JON P

  • Director
0 2019-06-13 3

STAAB THOMAS R II SENIOR VICE PRESIDENT AND CFO

  • Officer
125,176 2019-05-16 14

BABU YARLAGADDA S SENIOR VP - DRUG DISCOVERY

  • Officer
130,587 2019-01-31 3

POWELL LYNNE SENIOR VP - CCO

  • Officer
0 2019-01-25 12

SHERIDAN WILLIAM P SENIOR VP - CMO

  • Officer
1,638 2019-01-01 3

BARNES ALANE P SENIOR VP, CHIEF LEGAL OFFICER

  • Officer
77,530 2019-01-01 3

STEER RANDOLPH C

4,226 2018-10-25 0

LOWREY ROBERT S CFO, TREASURER, SECRETARY

  • Officer
1,000,000 2018-08-01 0

BIGGAR STEPHEN R

  • Director
0 2018-05-23 0

GRANT STUART EVP AND CFO

  • Officer
No longer subject to file 2017-08-29 0

SANDERS CHARLES A

  • Director
12,971 2016-02-29 0

HOROVITZ ZOLA P

  • Director
250,666 2015-12-08 0

BAKER BROS. ADVISORS (GP) LLC

  • Director
  • 10% Owner
0 2013-07-01 0

BAKER BROS ADVISORS LLC

  • 10% Owner
0 2012-04-12 0

MCCULLOUGH DAVID VP

  • Officer
24,124 2012-03-15 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
2,328,863 2012-03-12 0

14159 CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
57,704 2012-03-12 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
232,011 2012-03-12 0

BAKER BROS. CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
0 2012-01-27 0

BAKER / TISCH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
450,461 2011-12-30 0

FEATHERINGILL WILLIAM W

  • Director
  • 10% Owner
0 2010-05-13 0

MILLS MIKE PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2010-03-12 0

DARWIN MICHAEL A PRINCIPAL ACCOUNTING OFFICER

  • Officer
3,048 2008-07-31 0

BENNETT J CLAUDE CHIEF OPERATING OFFICER

  • Officer
  • Director
0 2008-03-14 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

THACKRAY HELEN M. - Director

2019-09-20 A 40,000 a 40,000 0.00 direct

ASELAGE STEVE - Director

2019-09-01 A 1,672 $2.99 a 6,672 6,672.00 direct

INGRAM ROBERT ALEXANDER - Director

2019-09-01 A 6,270 $2.99 a 28,088 28,088.00 direct

HUTSON NANCY J - Director

2019-09-01 A 3,344 $2.99 a 43,046 43,046.00 direct

HEGGIE THERESA - Director

2019-09-01 A 1,672 $2.99 a 1,672 1,672.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments